Fig. 1
From: Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma
The predictive value of IGF1R mutation in immunotherapy of melanoma. A Kaplan–Meier survival analysis comparing OS between IGF1R mutant and wildtype patients in the combination of five WES cohorts. B Multivariate Cox regression analysis of IGF1R mutations in WES cohorts with age, sex, tumor site and treatment method taken into account. C Comparison of the ORR between the IGF1R mutant and wildtype groups from WES cohorts. D Comparison of the DCR between the IGF1R mutant and wildtype groups from WES cohorts. E Kaplan–Meier survival analysis comparing OS between IGF1R mutant and wildtype patients in the MSKCC cohort. F Multivariate Cox regression analysis of IGF1R mutations in the combination of MSKCC cohort with age, sex, tumor sites and treatment methods were taken into account